ESR1 and breast carcinoma: In MCF-7 human breast cancer cells, Withaferin A treatment resulted in reduction in ER-α protein levels and pS2 levels, a product of ER-α regulated gene; this was attenuated in E2 presence (Hahm et al., 2011b).